Developer docs
API playgroundTry for free, no card

Search company profiles

Ubie

Full company profile

uuid02meuqg

Namestring
Ubie
Legal namestring
Ubie, Inc.
Websiteurl
ubiehealth.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Ubie, Inc. is a Tokyo-headquartered (with inferred US incorporation) digital health company founded in May 2017 by CEO Yoshinori Abe that operates an AI-powered symptom checker and related consumer health services across Japan, the United States, and other international markets. Its core product is a free, 3-minute AI-driven questionnaire that processes user-reported symptoms, demographics, and medical history to generate personalized reports on possible causes, treatment information, and guidance on when to seek medical care.

The platform is grounded in 50,000+ clinical data sources drawn from published scientific papers and is supervised by 50+ board-certified medical experts worldwide across specialties including emergency medicine, neurology, psychiatry, obstetrics and gynecology, cardiology, and internal medicine, drawn from institutions such as the Icahn School of Medicine at Mount Sinai, Penn State Health, and the U.S. Department of Veterans Affairs. An independent medrxiv comparative study reported a 71.6% top-10 hit accuracy for Ubie's symptom checker, outperforming competitor symptom checkers averaging approximately 60%. Supporting product lines include a doctor-authored Q&A database ("Doctor's Note"), targeted condition assessments ("Checkup"), and an AI-assisted support service ("Smart Support").

Ubie runs a product-led, freemium go-to-market with self-serve consumer access via ubiehealth.com, a Google Play mobile app, and Japan-specific domain ubie.app, requiring no credit card or account signup. The company extends into B2B through partnerships with over 900 medical institutions worldwide that both use and continuously train the AI system in real-world clinical practice. Specific pricing for premium or institutional tiers, revenue figures, funding rounds, and headcount are not publicly disclosed; the company is private with no parent entity or subsidiaries disclosed, and has no public listing.

Short descriptiontext

Ubie operates a free, AI-powered symptom checker that generates personalized reports on possible causes and care guidance for consumers, backed by 50,000+ clinical data sources and supervised by 50+ medical experts, with B2B partnerships across 900+ medical institutions in Japan, the US, and other markets.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI symptom checker, digital health platform, clinical decision support, patient symptom assessment, healthcare navigation software
Industry1 code
1Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
CodeHLACANADPrimaryYes
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Health / AI Symptom Assessment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Freemium Symptom Checker
TypeFreemium
Description

The core symptom checker is provided free to consumers. The company likely monetizes through premium services, partnerships with healthcare institutions, or B2B licensing of their medical AI technology. The exact revenue model details are not publicly disclosed.

ubiehealth.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Free symptom checker for consumers
ModelFreemiumBilling cadencePay-as-you-go
Notes

The core symptom checker service is free. No credit card required. No pressure to sign up for anything.

ubiehealth.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 of 4 records shown
1Symptom Checker
Description

AI-powered symptom assessment tool that generates personalized reports on possible causes in approximately 3 minutes.

ubiehealth.com
+3 more records
Core offering1 text field

Ubie provides a free AI-powered symptom checker that delivers personalized 3-minute assessments of possible causes based on user-reported symptoms, demographics, and medical history. The service is supervised by 50+ medical specialists and supported by 50,000+ clinical data sources, with additional offerings including Doctor's Note (physician-authored medical Q&A), Checkup (condition-specific assessments such as asthma), and Smart Support (AI-assisted health guidance).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 71.6% Top-10 hit accuracy demonstrated in independent medrxiv study, surpassing leading symptom checkers averaging ~60% accuracy
Product overview1 text field

Ubie is a healthcare AI company offering a suite of digital health services centered around its AI-powered symptom checker. The core product is the Symptom Checker, which uses artificial intelligence to analyze user-reported symptoms and generate personalized health reports. Supporting products include Doctor's Note (a database of doctor-written medical explanations), Checkup (targeted health assessments for specific conditions like asthma), and Smart Support (additional AI-powered guidance services). The platform is designed to help users understand their symptoms, identify possible causes, and determine when to seek professional medical care.

Product and service1 record
1Symptom Checker
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Medical Institutions Worldwide
Strategic tierCoreTypeOthers
Description

Over 900 medical institutions around the world trust Ubie's AI and continuously train the system through their clinical practice. This partnership provides Ubie with real-world clinical data and validation while offering institutions an AI-powered symptom assessment tool.

ubiehealth.com
2Supervising Medical Experts
Strategic tierCoreTypeOthers
Description

50+ medical experts worldwide, including board-certified specialists from institutions such as Icahn School of Medicine at Mount Sinai, Penn State Health, U.S. Department of Veterans Affairs, and other healthcare organizations, supervise and validate Ubie's medical content and AI.

ubiehealth.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ada Health offers an AI-powered symptom assessment app for consumers and B2B healthcare partners, closely matching Ubie's product, target users, and B2B clinical decision support model.

TypeDirect peer
Description

Buoy Health provides an AI-driven symptom checker that triages users to appropriate care and partners with health plans and providers, directly overlapping Ubie's consumer-triage + B2B-institution model.

TypeDirect peer
Description

Infermedica builds AI symptom-checking and triage APIs sold to insurers, providers, and telemedicine companies, paralleling Ubie's algorithmic triage and healthcare-institution channel.

TypeDirect peer
Description

Mediktor offers an AI symptom-checker and triage engine sold to hospitals, insurers, and telehealth platforms, mirroring Ubie's clinical decision support positioning and B2B go-to-market.

TypeDirect peer
Description

Babylon pioneered AI symptom triage and virtual care for consumers and provider systems; while its consumer app has wound down, its symptom-assessment technology and enterprise deployments remain comparable to Ubie's product surface.

TypeDirect peer
Description

K Health combines AI-driven symptom/triage with text-based primary care visits, overlapping Ubie's consumer symptom-check foundation and the care-navigation outcome Ubie recommends.

TypeBroad incumbent
Description

Mayo Clinic offers a clinician-authored symptom checker as part of a much broader consumer health information and care-delivery portfolio, providing a credible incumbent alternative for users comparing symptom tools.

TypeBroad incumbent
Description

WebMD operates a leading consumer health information site with a built-in symptom checker, serving the same top-of-funnel consumer need as Ubie but inside a broader advertising-supported media business.

TypeBroad incumbent
Description

Healthline publishes symptom and condition content at large scale and competes for Ubie's same consumer symptom-research audience, though without a comparable AI triage product.

TypeEmerging player
Description

Docus offers AI-augmented health consultations and symptom analysis, addressing a similar consumer pre-visit use case to Ubie but with a narrower product surface and earlier-stage traction.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ubie

Digital Health / AI Symptom Assessmentubiehealth.com

Ubie operates a free, AI-powered symptom checker that generates personalized reports on possible causes and care guidance for consumers, backed by 50,000+ clinical data sources and supervised by 50+ medical experts, with B2B partnerships across 900+ medical institutions in Japan, the US, and other markets.

What Ubie does

Ubie, Inc. is a Tokyo-headquartered (with inferred US incorporation) digital health company founded in May 2017 by CEO Yoshinori Abe that operates an AI-powered symptom checker and related consumer health services across Japan, the United States, and other international markets. Its core product is a free, 3-minute AI-driven questionnaire that processes user-reported symptoms, demographics, and medical history to generate personalized reports on possible causes, treatment information, and guidance on when to seek medical care.

The platform is grounded in 50,000+ clinical data sources drawn from published scientific papers and is supervised by 50+ board-certified medical experts worldwide across specialties including emergency medicine, neurology, psychiatry, obstetrics and gynecology, cardiology, and internal medicine, drawn from institutions such as the Icahn School of Medicine at Mount Sinai, Penn State Health, and the U.S. Department of Veterans Affairs. An independent medrxiv comparative study reported a 71.6% top-10 hit accuracy for Ubie's symptom checker, outperforming competitor symptom checkers averaging approximately 60%. Supporting product lines include a doctor-authored Q&A database ("Doctor's Note"), targeted condition assessments ("Checkup"), and an AI-assisted support service ("Smart Support").

Ubie runs a product-led, freemium go-to-market with self-serve consumer access via ubiehealth.com, a Google Play mobile app, and Japan-specific domain ubie.app, requiring no credit card or account signup. The company extends into B2B through partnerships with over 900 medical institutions worldwide that both use and continuously train the AI system in real-world clinical practice. Specific pricing for premium or institutional tiers, revenue figures, funding rounds, and headcount are not publicly disclosed; the company is private with no parent entity or subsidiaries disclosed, and has no public listing.

Ubie firmographics

Firmographics
Name
Ubie
Legal name
Ubie, Inc.
Website
https://ubiehealth.com
Company type
Private
Founded year
2017
Operating status
Operating
Short description
Ubie operates a free, AI-powered symptom checker that generates personalized reports on possible causes and care guidance for consumers, backed by 50,000+ clinical data sources and supervised by 50+ medical experts, with B2B partnerships across 900+ medical institutions in Japan, the US, and other markets.
Ownership category
akta.pro rank

Ubie industry classification

Industry
Product category
Digital Health / AI Symptom Assessment
SIC
Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

Keywords

  • AI symptom checker
  • Digital health platform
  • Clinical decision support
  • Patient symptom assessment
  • Healthcare navigation software

Where Ubie is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

Ubie business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Freemium Symptom Checker: The core symptom checker is provided free to consumers. The company likely monetizes through premium services, partnerships with healthcare institutions, or B2B licensing of their medical AI technology. The exact revenue model details are not publicly disclosed.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree symptom checker for consumers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Ubie product offering

Product offering

Core offering

Ubie provides a free AI-powered symptom checker that delivers personalized 3-minute assessments of possible causes based on user-reported symptoms, demographics, and medical history. The service is supervised by 50+ medical specialists and supported by 50,000+ clinical data sources, with additional offerings including Doctor's Note (physician-authored medical Q&A), Checkup (condition-specific assessments such as asthma), and Smart Support (AI-assisted health guidance).

Product overview

Ubie is a healthcare AI company offering a suite of digital health services centered around its AI-powered symptom checker. The core product is the Symptom Checker, which uses artificial intelligence to analyze user-reported symptoms and generate personalized health reports. Supporting products include Doctor's Note (a database of doctor-written medical explanations), Checkup (targeted health assessments for specific conditions like asthma), and Smart Support (additional AI-powered guidance services). The platform is designed to help users understand their symptoms, identify possible causes, and determine when to seek professional medical care.

Differentiator

Problem solved

Functional benefit

Brands

  • Symptom Checker: AI-powered symptom assessment tool that generates personalized reports on possible causes in approximately 3 minutes.
  • Doctor's Note
  • Checkup
  • Smart Support

Products and services

  • Symptom Checker

Quantifiable outcome

  • 71.6% Top-10 hit accuracy demonstrated in independent medrxiv study, surpassing leading symptom checkers averaging ~60% accuracy

Companies that use Ubie

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Ubie technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Ubie partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Medical Institutions WorldwidecoreOthersOver 900 medical institutions around the world trust Ubie's AI and continuously train the system through their clinical practice. This partnership provides Ubie with real-world clinical data and validation while offering institutions an AI-powered symptom assessment tool.
  • Supervising Medical ExpertscoreOthers50+ medical experts worldwide, including board-certified specialists from institutions such as Icahn School of Medicine at Mount Sinai, Penn State Health, U.S. Department of Veterans Affairs, and other healthcare organizations, supervise and validate Ubie's medical content and AI.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Ubie competitors and assessment

Company assessment

Direct peers

  • Ada Health: Ada Health offers an AI-powered symptom assessment app for consumers and B2B healthcare partners, closely matching Ubie's product, target users, and B2B clinical decision support model.
  • Buoy Health: Buoy Health provides an AI-driven symptom checker that triages users to appropriate care and partners with health plans and providers, directly overlapping Ubie's consumer-triage + B2B-institution model.
  • Infermedica: Infermedica builds AI symptom-checking and triage APIs sold to insurers, providers, and telemedicine companies, paralleling Ubie's algorithmic triage and healthcare-institution channel.
  • Mediktor: Mediktor offers an AI symptom-checker and triage engine sold to hospitals, insurers, and telehealth platforms, mirroring Ubie's clinical decision support positioning and B2B go-to-market.
  • Babylon Health (eMed): Babylon pioneered AI symptom triage and virtual care for consumers and provider systems; while its consumer app has wound down, its symptom-assessment technology and enterprise deployments remain comparable to Ubie's product surface.
  • K Health: K Health combines AI-driven symptom/triage with text-based primary care visits, overlapping Ubie's consumer symptom-check foundation and the care-navigation outcome Ubie recommends.

Broad incumbents

  • Mayo Clinic (Symptom Checker): Mayo Clinic offers a clinician-authored symptom checker as part of a much broader consumer health information and care-delivery portfolio, providing a credible incumbent alternative for users comparing symptom tools.
  • WebMD: WebMD operates a leading consumer health information site with a built-in symptom checker, serving the same top-of-funnel consumer need as Ubie but inside a broader advertising-supported media business.
  • Healthline: Healthline publishes symptom and condition content at large scale and competes for Ubie's same consumer symptom-research audience, though without a comparable AI triage product.

Emerging players

  • Docus: Docus offers AI-augmented health consultations and symptom analysis, addressing a similar consumer pre-visit use case to Ubie but with a narrower product surface and earlier-stage traction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Ubie social profiles

Digital presence

Ubie financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ubie leadership team

Management profile

Number of profiles

Profiles1 record

Ubie funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ubie M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ubie

What does Ubie do?

Ubie provides a free AI-powered symptom checker that delivers personalized 3-minute assessments of possible causes based on user-reported symptoms, demographics, and medical history. The service is supervised by 50+ medical specialists and supported by 50,000+ clinical data sources, with additional offerings including Doctor's Note (physician-authored medical Q&A), Checkup (condition-specific assessments such as asthma), and Smart Support (AI-assisted health guidance).

Is Ubie a public or private company?

Ubie is a private company. It is classified as unknown and is currently operating.

When was Ubie founded?

Ubie was founded in 2017.

Where is Ubie based?

Ubie is headquartered in Tokyo, Japan, in the Asia region.

How does Ubie make money?

One revenue line is on record: freemium Symptom Checker.

Who are Ubie's main competitors?

Direct peers on record are Ada Health, Buoy Health, Infermedica, Mediktor, Babylon Health (eMed) and K Health. Broad incumbents are Mayo Clinic (Symptom Checker), WebMD and Healthline. Docus is listed as an emerging player.

Does Ubie have an API?

No public API is recorded for Ubie.

What industry is Ubie in?

Ubie's product category is Digital Health / AI Symptom Assessment. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software. Its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales